Episode 61: Paxlovid Failures
Jun 16, 2022•19 min•Ep. 61
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
This week, we sat down with John Faragon to talk about a common drug for treating COVID-19 – nirmatrelvir with ritonavir or more widely known as Paxlovid. What is it? Who is it for? And, most importantly, why has it been failing?
--
Help us track the number of listeners our episode gets by filling out this brief form! (https://www.e2NECA.org/?r=PCS6722)
--
Want to chat? Email us at podcast@necaaetc.org with comments or ideas for new episodes.
--
Check out our free online courses: www.necaaetc.org/rise-courses
--
Download our HIV mobile apps:
Google Play Store: https://play.google.com/store/apps/developer?id=John+Faragon&hl=en_US&gl=US
Apple App Store: https://apps.apple.com/us/developer/virologyed-consultants-llc/id1216837691
For the best experience, listen in Metacast app for iOS or Android